38 results
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals
Induction therapy:
 • AmBd (0.7–1.0
IDSA Treatment Recommendations ... or ABLC (5 mg/kg ... Meningoencephalitis #IDSA ... #Treatment #management ... #cryptococcus #HIVAIDS
Wolff-Parkinson-White Syndrome

WPW is a congenital abnormality characterized by an abnormal accessory conduction pathway between the atria
pathway between the atria ... QRS interval on EKG ... The definitive treatment ... #EKG #Electrocardiogram ... #Clinical #Diagnosis
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... HIV-AIDS Preventing Clinical ... and preventing clinical ... Trypanosomiasis #IDSA ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... ., 4 mg/kg on days ... dose of 20–60 mg/kg ... Leishmaniasis #Prevention #Treatment ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... amphotericin B, 3 to 5 mg/kg ... Penicilliosis #IDSA ... #Prevention #Treatment ... opportunistic #infections #HIVAIDS
Candidemia Workup and Management - IDSA Guidelines
1) Antibiotics
 • Empiric: Echinocandins (e.g. micafungin) for most patients
and Management - IDSA ... Echinocandins (e.g ... or TEE unless clinical ... #Candidemia #IDSA ... #candidiasis #treatment
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
GrepMed Handbook Clinical ... Tx Management (IDSA ... Bezlotoxumab 10 mg/kg ... /severe CDI IDSA ... 2021 CDI Treatment
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
meningococcal, H1N1) Clinical ... Guillain-Barre Clinical ... Opthaloplegia • Ataxia ... Treatment: • Plasmapheresis ... diagnosis #management #treatment
Cannon A waves during AVNRT on Physical Exam
In AVNRT, the atria and ventricles contract nearly simultaneously
In AVNRT, the atria ... EKG of the same ... excludes other differentials ... that’s called “clinical
Multiple Sclerosis - Summary

Multiple Sclerosis (MS) is an autoimmune-mediated neurodegenerative disease of the central nervous system
Cramping, Weakness, Ataxia ... patients with clinically ... stimulation Clinical ... Multiple Sclerosis Treatment ... management #neurology #treatment